Enliven Therapeutics
ELVN
#5266
Rank
HK$9.25 B
Marketcap
HK$189.50
Share price
3.48%
Change (1 day)
107.59%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$0.13 Billion

According to Enliven Therapeutics's latest financial reports the company's total liabilities are HK$0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.20 B-83.79%
2022-12-31HK$1.25 B2.71%
2021-12-31HK$1.21 B3.85%
2020-12-31HK$1.17 B